NCT06729268Completed
Fluid Responsiveness Tests in Critically Ill Patients During Admission to the Intensive Care Unit
Possibility of Applying Fluid Responsiveness Tests in Critically Ill Patients During Admission to the Intensive Care Unit - a Prospective Observational Study.
Source: ClinicalTrials.gov · Last updated 31 Dec 2024
Brief summary (registry, in English)
The goal of this observational study is to investigate the prevalence of conditions allowing the performance fluid responsiveness tests in critically ill patients during admission to the intensive care unit.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 389 (actual)
- First submitted
- 7 Dec 2024
- Start date
- 3 Apr 2023
- Primary completion date
- 27 May 2024
- Lead sponsor
- Uniwersytecki Szpital Kliniczny w Opolu
- Diseases
- Heart failure
- NCT number
- NCT06729268
What you commit to
- Study type: Observational
- Participants enrolled: 389
- From 3 Apr 2023 to the primary completion date, 27 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age under 18
Other
- The researcher unavailable in the intensive care unit
- Patient assessment cannot be completed within the first six hours after admission to the ICU
Who the study is looking for
- 1\. Adult patients admitted to the intensive care unit
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Anesthesiology and Intensive Care, Uniwersytecki Szpital Kliniczny w Opolu Coordinator of this site? Confirm its status | Opole | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.